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Membrane curvatureOver the last decade, compelling evidence has linked the development of Alzheimer's disease (AD) to defective
intracellular trafﬁcking of the amyloid precursor protein (APP). Faulty APP trafﬁcking results in an overproduction
of Aβ peptides, which is generally agreed to be the primary cause of AD-related pathogenesis. LR11 (SorLA), a type I
transmembrane sorting receptor, has emerged as a key regulator of APP trafﬁcking and processing. It directly
interacts with APP and diverts it away from amyloidogenic processing. The 54-residue cytosolic domain of LR11
is essential for its proper intracellular localization and trafﬁcking which, in turn, determines the fate of APP. Here,
we have found a surprising membrane-proximal amphipathic helix in the cytosolic domain of LR11. Moreover, a
peptide corresponding to this region folds into an α-helical structure in the presence of liposomes and transforms
liposomes to small vesicles and tubule-like particles.We postulate that this amphipathic helixmay contribute to the
dynamic remodeling ofmembrane structure and facilitate LR11 intracellular transport. This article is part of a Special
Issue entitled: NMR Spectroscopy for Atomistic Views of Biomembranes and Cell Surfaces. Guest Editors: Lynette
Cegelski and David P.Weliky.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Alzheimer's disease (AD) is a neurodegenerative disease that
currently affects more than 36 million people worldwide. It is generally
accepted that an accumulation of amyloid-β (Aβ) peptides in the brain
is the primary cause of AD [1–3]. While the chemistry of Aβ generation
from sequential proteolysis of the amyloid precursor protein (APP) by
β- and γ-secretases is well understood, the underlying causes of Aβ
peptide overproduction are much more complex [4]. In fact the vast
majority of AD patients do not have genetic defects that would disrupt
these proteolytic processes. Recent studies have established a link
between aberrant subcellular trafﬁcking of APP and increased Aβ
production [4–7]. This is conceivable since both APP and secretases
are transmembrane proteins and sorted through multiple subcellular
organelles (e.g. trans-Golgi network (TGN), plasma membrane,
endosomes) [8–10]. As a result, their spatial and temporal subcellular
distributions are subjected to transport regulations. Indeed, alteredolic domain; APP, amyloid pre-
binding protein; DMPC, 1,2-
1,2-dioleoyl-sn-glycero-3-
ol; PTA, phosphotungstic acid;
ctroscopy for Atomistic Views of
egelski and David P.Weliky.
1 717 531 7072.expression of several trafﬁcking factors results in abnormal Aβ levels
[11–13]; variants in genes associated with endocytosis and retromer
sorting pathways have been identiﬁed as potential AD risk factors [14].
A key regulator of APP trafﬁcking is LR11 (also known as SorLA)
[15–17]. LR11 is a 250-kDa type-1 membrane protein highly expressed
in the brain and belongs to the family of vacuolar protein sorting 10
(Vps10) receptors [18–22]. Vps10 proteins interact with the retromer
complex for protein intracellular trafﬁcking. LR11 directly interacts
with APP via the cluster of complement-type repeats in its ectomain
domain [23] and diverts it away from amyloidogenic processing to Aβ
peptides. LR11 displays tight binding to APP in vitro and co-localizes
with APP in living cells, as seen in co-immunoprecipitation and
ﬂuorescence-lifetime imaging microscopy (FLIM) experiments [15,23,
24]. The importance of LR11 in the pathophysiology of AD is highlighted
by the observations of poor LR11 expression in the brain of patients
suffering from sporadic AD [25–27]. A recent report indicates that subtle
changes in the level of LR11 expression could signiﬁcantly affect the
production of Aβ peptides [28]. Furthermore, variants of the LR11
gene have been associated with potential risks for the development of
AD [29].
LR11 consists of a large ectodomain, a transmembrane domain (TM),
and a cytosolic domain (CT). Its proper subcellular localization to the
TGN and trafﬁcking itineraries, which rely on sorting motifs within the
CT, are required for regulating the ﬁnal fate of APP. The 54-residue
LR11 CT is highly conserved amongmammals (~95% sequence identity)
and harbors multiple functionally important motifs, including an
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(DDLGEDDED) (Fig. 1(A)). These motifs interact with adaptor proteins
that mediate transports between the trans-Golgi network (TGN) and
endosomes, such as GGA proteins, AP-1, AP-2, and PACS-1 [30–32].
Disruptions of LR11–GGA and LR11–AP1 interactions lead to the aberrant
trafﬁcking of LR11 and result in faulty APP trafﬁcking and processing [33].
Furthermore, the LR11-mediated reduction of Aβ peptide is dependent
on the phosphorylation of a serine residue in CT [34]. It also has been
suggested that the LR11 CT may directly regulate transcription after
metalloprotease TACE and γ-secretase cleavages [35].RSTDVAAVVV10 PILFLILLSL20 GVGFAILYTK30
HRRLQSSFTA40 FANSHYSSRL50 GSAIFSSGDD60
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Fig. 1. Secondary structures of LR11 TMCT from NMR chemical shift analysis. (A) Primary
sequence of LR11 TMCT, corresponding to residues 2132 to 2214 of the full-length protein.
Amino acids underlined by a solid line are from the TM domain, and those underlined by
dashed lines belong to two functionally important motifs: an acid cluster region and a
GGA-binding site (dileucine-like motif), respectively. These motifs interact with adaptor
proteins that mediate Golgi to endosome transport. (B) 15N–1H TROSY spectrum of
2H,13C,15N labeled LR11 TMCT in deuteratedDPCmicelles showing resonance assignments
(resonances from tags are not labeled). (C) 13Cα secondary chemical shifts of LR11 TMCT
(Cα, LR11 TMCT–Cα, random coil, 2H isotope shifts were corrected using the program
TALOS+) indicate two α-helical regions: a TM helix includes residues Val5 to Tyr28 and
a membrane proximal helix includes residues Leu34 to Ile54.In this study, we characterize the secondary structure of LR11 CT
together with its native membrane anchor, the TM, in a membrane
mimic environment using high resolution NMR spectroscopy. We
identify a surprising membrane proximal amphipathic α-helix in LR11
CT. This helix interacts with liposomes mimicking the Golgi apparatus
lipid composition and, moreover, deforms liposomes. We suggest that
this helix may play an active role in remodeling membrane structures
during vesicular trafﬁcking and facilitating the transport of LR11
between subcellular compartments.
2. Materials and methods
2.0.1. Overexpression and puriﬁcation of LR11 TMCT
LR11 TMCT protein was expressed and puriﬁed as previously
described [36].
2.0.2. LR11 CT30–60 peptide
LR11CT30–60 peptidewas synthesized andpuriﬁed to N90%purity by
GenScript. The peptidewas dissolved in either 2.5% acetic acid for circular
dichroism (CD) and dynamic light scattering (DLS) experiments or 8 M
urea for electron microscopy (EM) experiments at 1 mg/mL. These
stock solutions were diluted to 0.1 mg/mL (33 μM) with a buffer of
75 mM Hepes at pH 7.5 prior to use.
2.0.3. NMR spectroscopy
All NMR spectra were recorded at 37 °C on a Bruker 600 MHz spec-
trometer equipped with a cryoprobe unless otherwise speciﬁed. TROSY
based 3D HNCA, HNCA-intra [31], HNCACB and CBCA(CO)NH data were
acquired on a sample of 1 mM, U–2H,15N,13C labeled protein in 20 mM
phosphate, 100 mM NaCl, pH 7.0, and 4.5% DPC solution for backbone
resonance assignments. NMR data were processed with NMRPipe and
analyzed using Sparky and NMRView softwares.
2.0.4. Liposome preparation
Lipids in chloroform solution were purchased from Avanti Polar
Lipids. Small unilamellar liposomes were prepared by either sonication
or extrusion method. First, the lipid solution was evaporated to a dried
ﬁlm. The dried ﬁlm was then hydrated in an aqueous buffer at 40 °C
for 1 h to form a lipid suspension. For CD measurements, the lipid
suspension, after ﬁve cycles of freezing and thawing, was sonicated in
a 40 °C water bath until transparent. For DLS and EM experiments, the
lipid suspension was prepared by successive extrusion through 1 μm,
0.1 μm, and 0.05 μmpolycarbonate ﬁlter 11 times using a hand extruder
(Avanti). Debris was removed by spinning the liposome solution at
14,000 g on a desktop centrifuge for 10min. Liposomes of two different
compositions were prepared with either DMPC lipids or a mixture of
egg PC (50%, molar ratio), DOPE (30%), Brain PS (10%), and 1,2-DOG
(10%) to mimic lipid compositions of the Golgi membrane [37,38].
Liposomes were stored at room temperature and used within 3 days
of preparation.
2.0.5. Circular dichroism spectroscopy
CD spectra in the far UV (200–250 nm)were recorded at 25 °C using a
quartz cell with an optical path length of 0.02 cm on a Jasco 710J-spectro-
polarimeter. The instrumentwas set at 2 nm bandwidth and 2 s response
time. LR11 CT30–60 peptide at 33 μm was incubated with liposomes for
5 min in a buffer of 11.25 mM HEPES, pH 7.5 before CD measurement.
For each CD spectrum, 6 scans were collected and averaged with a
scan rate of 50 nm/min and 1 nm interval. All spectra were corrected
for background signals from an aqueous liposome solution.
2.0.6. Dynamic light scattering
DLS data were collected at 25 °C on a Viscotek 802 DLS instrument
(Malvern). LR11 CT30–60 peptide at 8 μM was incubated with 27.2,
109.6, and 438.4 μM lipids, respectively, for 5 min before measurement.
Data was processed and analyzed using OmniSize software.
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Fig. 2. (A) CD spectra of LR11 CT30–60 peptide in aqueous solution and liposomesmimicking
the Golgi apparatus lipid composition. The peptide concentration is 33.3 μM. (B) Helical
wheel plot of LR11 CT34–48.
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Micrographs were taken at an initial magniﬁcation of 28,500 with a
Jeol JEM 1400 transmission electron microscope (Phillips) operating at
60 kV. Before staining, 21.5 μM LR11 CT30–60 peptide was incubated
with 500 μM liposomes for 10 min at room temperature. Negatively
stained samples were prepared by applying 5 μL drops of sample to
Formvar-coated 400 mesh copper grids for 2 min, then blotting excess
sample, followed by staining, 20 s each, in 3 successive drops of 1%
(w/v) PTA pH 7.0, and a ﬁnal blotting of excess stain.
3. Results
3.1. NMR secondary structure analysis of LR11 TMCT in DPC micelles
Using an MBP-fusion construct (Fig. S1) we have succeeded in
preparing recombinant human LR11 TMCT protein as described
previously [36]. The fusion protein, mainly expressed in Escherichia coli
membranes, was extracted from membrane with detergents and ﬁrst
puriﬁed using a Ni-NTA column. LR11 TMCT was then cleaved from the
fusion partner and further puriﬁed and reconstituted into a DPC micelle
solution. A 2D 1H–15N TROSY spectrum of 2H,13C,15N-labeled LBT-LR11
TMCT preparation is shown in Fig. 1(B). The spectrum displays good
quality with typical chemical shift dispersion for a helical protein. 8
out of 9 expected glycines are observed. Furthermore, the spectrum
resembles the data collected from LR11 TMCT in bilayer-like bicelle
solution (Fig. S2a), where the protein displays expected interactions
with the VHS domain of GGA (Fig. S2b) [30,39]. Thus, LR11 TMCT likely
maintains its native state in DPC micelles.
We have assigned ~90% of backbone residues using several TROSY-
based triple resonance experiments. Most of the unassigned residues
are in regions between TM and CT. Analysis of the secondary shifts of
assigned 13Cα indicates two helical segments: a transmembrane helix
spanning residues Val5 to Tyr28 as predicted, and an unanticipated
membrane proximal helix at the N-terminal region of CT extending
from residues Leu34 to Ile54 (Fig. 1(C)). The rest of the LR11 CT (from
residues Ser56 to Ala83) appears to lack stable regular secondary
structure. These predictions are further supported by the backbone
torsion angles derived from the TALOS+program(listed in Supplemental
Table S1) and the chemical shift index (CSI) analysis of assigned chemical
shifts of Cα, Cβ, and C′ (Fig. S3). In addition, resonances fromunstructured
regions at the C-terminal half of LR11 CT consistently show strong
intensities.
3.2. Membrane induced α-helical folding of the N-terminal region of LR11 CT
While previous studies have identiﬁed two functionally important
motifs at the C-terminal half of LR11 CT [31], little is known about the
signiﬁcance of the N-terminal region of LR11 CT except that the
sequence of FANSHY (residues 41 to 46) may be a recognition motif for
the VPS26 subunit of the retromer complex [40]. To further characterize
the putative N-terminal membrane proximal helix of LR11 CT, a peptide
that corresponds to residues K30 to D60, LR11 CT30–60, was synthesized.
CD spectra were collected in aqueous buffer and in liposome solution in
order to determine if this peptide can form an α-helical structure in the
absence of LR11 TM. As shown in Fig. 2(A), the CD spectrum of LR11
CT30–60 peptide in aqueous solution at a concentration of 33.3 μMdisplays
typical features of a random coil structure. In contrast, in the presence of
liposomes, this peptide produces negative ellipticity at 208 and 222 nm,
clearly indicating that the peptide folds to α-helical structures. Thus the
membrane proximal region of LR11 CT has an intrinsic propensity to
adopt helical structures in lipid environments, independent of its
transmembrane domain. In addition, this folding process appears to
depend on the lipid composition of membrane vesicles. While liposomes
with lipid compositions that resemble those of Golgi membrane induce
α-helical folding of LR11 CT30–60, the peptide remains unstructured in
the presence of DMPC-liposomes (data not shown). This is likely due toloose lipid packing of liposomeswith aGolgi-like composition as opposed
to the presence of negative charged [38], since this peptide also folds to a
helical structure in neutral DPC micelles (Fig. S4).
A helical wheel analysis of this membrane proximal region provided
some molecular insights into its interactions with the lipid bilayer. As
shown in Fig. 2(B), the majority of this region (residues L34 to S48)
adopts an amphipathic α-helix structure. The hydrophilic face of this
helix mainly consists of polar residues, while the hydrophobic face
includes nonpolar amino acids and a histidine. When it is uncharged,
the histidine residue prefers a hydrophobic environment. Amphipathic
helices are particularly suited for effectively interacting with the
membrane. As they bind to the membrane, the hydrophilic side of
amphipathic helices can interact with the lipid head groups while the
hydrophobic surface interacts with lipid acetyl chains. Together, our
data suggest that the N-terminal membrane proximal region of LR11
CT forms an amphipathic α-helix and interacts with the lipid bilayer.
3.3. Membrane remodeling by the N-terminal region of LR11 CT
The amphipathic helix is a common motif that mediates protein
interactions with membrane. Some of its classic roles include acting as
a membrane anchor and membrane-destabilizing agent. Recently,
amphipathic helices have been implicated in sensing and modifying
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Fig. 3. LR11 CT30–60 peptide remodels liposomes mimicking the Golgi apparatus lipid
composition. (A) DLS data of extruded liposome solution in the absence and presence of
the peptide. The peptide concentration is at 8 μM. (B) Electron micrographs of negatively
stained vesicle in the absence and presence of the peptide. The liposome concentration is
500 μM.
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of LR11 CT30–60 interactionswith themembrane, wemeasured the sizes
and size-distributions of liposomes incubated with and without LR11
CT30–60 peptides using DLS. Changes in these parameters provide
insights into the extent of membrane perturbations upon peptide
binding. For DLS experiments, relative homogenous liposomes
were prepared by extrusion method. As shown in Fig. 3(A), DLS
measurement conﬁrms the homogeneity of our preparations with an
average mean diameter of 70 ± 20 nm. These liposomes are stable and
few changes are detected for several days. In contrast, after incubating
with the LR11 CT30–60 peptide for 10 min, dramatic changes in liposome
sizes and size-distributions are observed. At a high lipid-to-peptide
molar ratio of 54.8:1, the mean size of liposomes changes slightly yet
the size distributions were almost double. When lipid-to-peptide molar
ratios decrease to below14:1, DLS data indicate that the solution becomes
polydisperse. In a control experiment, solution with LR11 CT30–60
peptides alone at the same concentration remains monodisperse (data
not shown). Thus DLS data suggest that the binding of LR11 CT30–60 to
liposomes may alter their shapes and sizes.
We directly visualized the effect of LR11 CT30–60 binding on liposomes
using negative staining and EM. Extruded liposomes show vesicles of
relatively similar sizes with an average size of about 60 nm (Fig. 3(A)).
By contrast, at a lipid-to-peptide molar ratio of 23:1 these liposomes are
clearly deformed into signiﬁcantly smaller vesicles coexisting with
some tubule-like particles as seen in Fig. 3(B). These tubule-like particles
are likely responsible for the observed increase in vesicle sizes seen in
Fig. 3(A) since DLS measurements are more sensitive to larger particles.
Together, our results indicate that the LR11 CT30–60 peptidemay efﬁciently
reshape membrane structures in vitro.
4. Discussion
Intracellular transport requires the constant budding and fusion of
membrane-bound trafﬁcking vesicles. During this process, membrane
geometry is concomitantly remodeled. The generation, recognition,
and regulation of membrane structure depend on a complex interplay
between proteins and lipids, proteins and proteins, and lipids and lipids.
Despite its structural simplicity, the amphipathic helix has emerged as
one of themost commonmotifs invoked to sense andmodulate curved
membranes [45–50]. Once folded, amphipathic helices usually reside
within the interfacial zone with its hydrophilic face interacting with
lipid polar groups and its hydrophobic side penetrating into the hydro-
carbon core of the bilayer. Insertion of a hydrophobic region into one
leaﬂet of the bilayer changes the bilayer symmetry and perturbs lipid
packing, thereby presenting the potential for sensing and inducing
membrane curvature. Increasing numbers of membrane-bending
amphipathic helices have been found in proteins involved in endocytosis
and vesicular trafﬁcking, in viral proteins, and in several peripheral
membrane proteins. Examples include N-BAR domain containing
proteins such as amphiphysin and endophilin [51], small GTP-binding
proteins such as Arf and Sar1 [52], M2 protein from Inﬂuenza virus [53],
Tip protein from Herpesvirus saimiri [54], Pex11 protein involved in per-
oxisome proliferation [55], and CTP: phosphocholine cytidylyltransferase
which regulates phosphatidylcholine synthesis [56]. Here we report that
a putative membrane-proximal amphipathic helix in LR11 CT deforms li-
posomes in vitro. This helix is short and has a small hydrophobic face
(Fig. 2(B)), similar to the membrane-bending H0 helix in Epsin [45,51],
a protein that contributes to the formation of clathrin-coated vesicles.
However, unlike the H0 helix, the hydrophilic face of the LR11 CT helix
does not contain charged residue, a feature that was previously ascribed
to a class of amphipathic helices that senses but does not induce
membrane curvature [42,57]. It remains to be seen if the LR11 CT helix
can also function as a curvature sensor. On the other hand, our current
knowledge about membrane structure rearrangement remains qualita-
tive; a detailed understanding of the underlying molecular mechanism
requires further study [58–60].The cytosolic domain of LR11 contains multiple motifs that are
responsible for its intracellular trafﬁcking and subcellular localization
[30]. Functional interactions of these motifs with adaptor proteins that
mediate Golgi body-endosome transports determine the proper subcel-
lular location and intracellular trafﬁcking of LR11, which in turn are
critical for protecting APP from amyloidogenic processing. As shown
327R.L. Gill Jr. et al. / Biochimica et Biophysica Acta 1848 (2015) 323–328previously, faulty trafﬁcking of LR11 leads to aberrant APP processing and
enhanced Aβ peptide production. LR11 is recruited to carrier vesicles pri-
marily by adaptor proteins such asGGAvia the acidic-dileucine-likemotif
in its cytosolic domain [30,61]. While the basics of vesicular biogenesis
have been described, the precise molecular mechanisms responsible for
membrane deformation and vesicle budding have not been clearly eluci-
dated. It is generally believed that Arf and coat proteins mediate these
processes [62–64]. In the present study, we found that the membrane
proximal helix of LR11 CT deforms liposomes, suggesting that this sorting
receptor may also actively participate in alteringmembrane structure for
vesicle formation. This hypothesis needs to be tested both in vivo and
in vitro using the full length LR11, but it is worth noting that an amphi-
pathic helix within the cytosolic tail of the M2 protein alone is sufﬁcient
for Inﬂuenza virus scission [53].
A recent study reported that mutations in the F41ANSHY46 motif, in
particular the F41A mutant, within the putative helix of LR11 CT
disrupted its interaction with the retromer complex and resulted in
altered LR11 subcellular localization [40]. This membrane proximal
region may perform dual functional roles. Previously, an amphipathic
helix preceding the transmembrane domain of the Herpesviral protein
Tip has been shown tomediate both lipid raft localization andmembrane
deformation [54]. On the other hand, aromatic residues are known to be
critical for protein–lipid interactions. The F41A mutation will also likely
affect the binding of the LR11 CT helix to the membrane bilayer besides
abolishing its interaction with the retromer complex.
In summary, we have identiﬁed a membrane proximal helix at the
N-terminal region of LR11 CT from an analysis of NMR chemical shifts.
We have shown that the folding of this helix at the membrane surface
is independent of the LR11 TM helix. This helix has characteristic
features of an amphipathic helix and interacts with liposomes,
transforming them to small vesicles and tubule-like particles. Since
the change in membrane geometry is an inherent part of vesicular
transport, we speculate that LR11may play an active role in remodeling
membrane structure and facilitating the intracellular trafﬁckingprocess.
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